|
![]() |
|||
|
||||
OverviewThis volume comprehensively covers the multiplicity and diversity of mechanisms underlying patient resistance to currently approved anti-cancer drugs, including tyrosine kinase inhibitors and monoclonal antibodies, blockers of growth factor receptors and their downstream pathways, which play essential functions in cancer progression. Each chapter will cover a specific group of targets and the cognate drugs, along with molecular modes of innate and evolving resistance. Full Product DetailsAuthor: Yosef Yarden , Moshe ElkabetsPublisher: Springer International Publishing AG Imprint: Springer International Publishing AG Edition: 2018 ed. Volume: 15 Weight: 0.565kg ISBN: 9783319679303ISBN 10: 3319679309 Pages: 242 Publication Date: 10 April 2018 Audience: Professional and scholarly , College/higher education , Professional & Vocational , Postgraduate, Research & Scholarly Format: Hardback Publisher's Status: Active Availability: Manufactured on demand ![]() We will order this item for you from a manufactured on demand supplier. Table of ContentsReviewsAuthor InformationYosef Yarden, PhD, is Professor, Department of Biological Regulation, The Weizmann Institute of Science, Israel. Tab Content 6Author Website:Countries AvailableAll regions |